Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Association between the timing of surgery for complicated, left-sided infective endocarditis and survival.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Jan 17;210:108-116. doi: 10.1016/j.ahj.2019.01.004. [Epub ahead of print]

PMID:
30802708
2.

Dynamics and management of oral anticoagulant treatment in chronic hepatitis C patients undergoing therapy with direct antiviral agents.

Vitrone M, Parrella A, Albisinni R, Durante-Mangoni E, Zampino R.

J Chemother. 2019 Feb 20:1-4. doi: 10.1080/1120009X.2019.1571661. [Epub ahead of print]

PMID:
30784359
3.

Liver histopathological findings in advanced heart failure: a reappraisal of cardiac cirrhosis concept.

Durante-Mangoni E, Parrella A, Pafundi PC, Vitrone M, Ragone E, De Rosa I, Amarelli C, Zampino R.

Intern Emerg Med. 2019 Jan 28. doi: 10.1007/s11739-019-02033-3. [Epub ahead of print]

PMID:
30689135
4.

Infective Endocarditis in the Elderly: Diagnostic and Treatment Options.

Ursi MP, Durante Mangoni E, Rajani R, Hancock J, Chambers JB, Prendergast B.

Drugs Aging. 2019 Feb;36(2):115-124. doi: 10.1007/s40266-018-0614-7.

PMID:
30488173
5.

Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial.

Dickstein Y, Lellouche J, Dalak Amar MB, Schwartz D, Nutman A, Daitch V, Yahav D, Leibovici L, Skiada A, Antoniadou A, Daikos GL, Andini R, Zampino R, Durante-Mangoni E, Mouton JW, Friberg LE, Benattar YD, Bitterman R, Neuberger A, Carmeli Y, Paul M; AIDA study group.

Clin Infect Dis. 2018 Nov 20. doi: 10.1093/cid/ciy988. [Epub ahead of print]

PMID:
30462182
6.

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility.

Lellouche J, Schwartz D, Elmalech N, Ben Dalak MA, Temkin E, Paul M, Geffen Y, Yahav D, Eliakim-Raz N, Durante-Mangoni E, Iossa D, Bernardo M, Daikos GL, Skiada A, Pantazatou A, Antoniadou A, Mouton JW, Carmeli Y; AIDA study group.

Clin Microbiol Infect. 2018 Oct 4. pii: S1198-743X(18)30636-0. doi: 10.1016/j.cmi.2018.09.014. [Epub ahead of print]

PMID:
30291971
7.

Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy.

Zampino R, Capoluongo N, Boemio A, Macera M, Vitrone M, Adinolfi LE, Filippini P, Sagnelli E, Sagnelli C, Durante-Mangoni E, Coppola N.

Can J Gastroenterol Hepatol. 2018 Jul 26;2018:5670374. doi: 10.1155/2018/5670374. eCollection 2018.

8.

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.

Zak-Doron Y, Dishon Benattar Y, Pfeffer I, Daikos GL, Skiada A, Antoniadou A, Durante-Mangoni E, Andini R, Cavezza G, Leibovici L, Yahav D, Eliakim-Raz N, Carmeli Y, Nutman A, Paul M; AIDA Study Group .

Clin Infect Dis. 2018 Nov 28;67(12):1815-1823. doi: 10.1093/cid/ciy371.

PMID:
29718143
9.

Colistin versus colistin plus meropenem for severe infections Authors' reply.

Paul M, Carmeli Y, Daikos GL, Durante-Mangoni E, Theuretzbacher U, Mouton JW, Leibovici L.

Lancet Infect Dis. 2018 May;18(5):495-496. doi: 10.1016/S1473-3099(18)30223-8. No abstract available.

PMID:
29695358
10.

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.

Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L.

Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16.

PMID:
29456043
11.

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.

Zampino R, Lebano R, Coppola N, Macera M, Grandone A, Rinaldi L, De Sio I, Tufano A, Stornaiuolo G, Adinolfi LE, Durante-Mangoni E, Battista GG, Niglio A.

Saudi J Gastroenterol. 2018 Jan-Feb;24(1):25-29. doi: 10.4103/sjg.SJG_100_17.

12.

Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.

Papst L, Beović B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M; ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group.

Clin Microbiol Infect. 2018 Oct;24(10):1070-1076. doi: 10.1016/j.cmi.2018.01.015. Epub 2018 Feb 1.

PMID:
29410094
13.

The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts.

Concia E, Viscoli C, Del Bono V, Giannella M, Bassetti M, De Rosa GF, Durante Mangoni E, Esposito S, Giusti M, Grossi P, Menichetti F, Pea F, Petrosillo N, Tumbarello M, Stefani S, Venditti M, Viale P; group of Italian Experts.

J Chemother. 2018 May;30(3):157-171. doi: 10.1080/1120009X.2017.1420610. Epub 2018 Jan 30.

PMID:
29380676
14.

Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Falcone M, Tiseo G, Durante-Mangoni E, Ravasio V, Barbaro F, Ursi MP, Pasticci MB, Bassetti M, Grossi P, Venditti M, Rizzi M.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02208-17. doi: 10.1128/AAC.02208-17. Print 2018 Apr.

15.

Direct antiviral treatment of chronic hepatitis C in heart transplant recipients.

Vitrone M, Andini R, Mattucci I, Maiello C, Atripaldi L, Durante-Mangoni E, Zampino R.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12813. Epub 2017 Dec 21.

PMID:
29139181
16.

Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact.

Vitrone M, Iossa D, Rinaldi L, Pafundi PC, Molaro R, Parrella A, Andini R, Ragone E, Maiello C, Zampino R, Durante-Mangoni E.

J Clin Virol. 2017 Nov;96:54-59. doi: 10.1016/j.jcv.2017.09.011. Epub 2017 Sep 23.

PMID:
28964958
17.

Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.

Zampino R, Vitrone M, Parrella A, Ragone E, Durante-Mangoni E.

J Chemother. 2018 Apr;30(2):129-130. doi: 10.1080/1120009X.2017.1376782. Epub 2017 Sep 19.

PMID:
28925824
18.

Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis.

Giuliano S, Guastalegname M, Russo A, Falcone M, Ravasio V, Rizzi M, Bassetti M, Viale P, Pasticci MB, Durante-Mangoni E, Venditti M.

Expert Rev Anti Infect Ther. 2017 Sep;15(9):807-818. doi: 10.1080/14787210.2017.1372749. Epub 2017 Sep 14. Review.

PMID:
28903607
19.

Reply to Letter: Influence of Liver and Kidney Disease on Sofosbuvir Electrophysiological Effects.

Vitrone M, Parrella A, Durante-Mangoni E.

J Clin Pharmacol. 2017 Jul;57(7):933-934. doi: 10.1002/jcph.915. Epub 2017 May 3. No abstract available.

PMID:
28467601
20.

Infection of Retained Defibrillator Lead Fragment after Heart Transplant.

Durante-Mangoni E, Vitrone M, Mattucci I, Caprioli V, Maiello C.

Clin Pract. 2017 Apr 6;7(2):857. doi: 10.4081/cp.2017.857. eCollection 2017 Apr 6.

21.

International experts' practice in the antibiotic therapy of infective endocarditis is not following the guidelines.

Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G, Fernandez-Gerlinger MP, Mainardi JL, Tattevin P, Revest M, Lucht F, Botelho-Nevers E, Gagneux-Brunon A, Snygg-Martin U, Chan KL, Bishara J, Vilacosta I, Olmos C, San Román JA, López J, Tornos P, Fernández-Hidalgo N, Durante-Mangoni E, Utili R, Paul M, Baddour LM, DeSimone DC, Sohail MR, Steckelberg JM, Wilson WR, Raoult D.

Clin Microbiol Infect. 2017 Oct;23(10):736-739. doi: 10.1016/j.cmi.2017.03.007. Epub 2017 Mar 18.

22.

Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.

Pericàs JM, Messina JA, Garcia-de-la-Mària C, Park L, Sharma-Kuinkel BK, Marco F, Wray D, Kanafani ZA, Carugati M, Durante-Mangoni E, Tattevin P, Chu VH, Moreno A, Fowler VG Jr, Miró JM; International Collaboration on Endocarditis Microbiology Investigators.

Clin Microbiol Infect. 2017 Aug;23(8):544-549. doi: 10.1016/j.cmi.2017.01.017. Epub 2017 Feb 1.

23.

Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C.

Durante-Mangoni E, Parrella A, Vitrone M, Rago A, Pafundi PC, Nigro G, Utili R, Russo V.

J Clin Pharmacol. 2017 Jul;57(7):924-930. doi: 10.1002/jcph.872. Epub 2017 Jan 24.

PMID:
28117887
24.

Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study.

Iossa D, Molaro R, Andini R, Parrella A, Ursi MP, Mattucci I, De Vincentiis L, Dialetto G, Utili R, Durante-Mangoni E.

Medicine (Baltimore). 2016 Sep;95(39):e4972. doi: 10.1097/MD.0000000000004972.

25.

Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.

Durante-Mangoni E, Andini R, Signoriello S, Cavezza G, Murino P, Buono S, De Cristofaro M, Taglialatela C, Bassetti M, Malacarne P, Petrosillo N, Corcione A, Viscoli C, Utili R, Gallo C.

Clin Microbiol Infect. 2016 Dec;22(12):984-989. doi: 10.1016/j.cmi.2016.08.004. Epub 2016 Aug 18.

26.

Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.

Carugati M, Petti CA, Arnold C, Miro JM, Pericàs JM, Garcia de la Maria C, Kanafani Z, Durante-Mangoni E, Baddley J, Wray D, Klein JL, Delahaye F, Fernandez-Hidalgo N, Hannan MM, Murdoch D, Bayer A, Chu VH.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6341-9. doi: 10.1128/AAC.01531-16. Print 2016 Oct.

27.

MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management.

Scudeller L, Bassetti M, Concia E, Corrao S, Cristini F, De Rosa FG, Del Bono V, Durante-Mangoni E, Falcone M, Menichetti F, Tascini C, Tumbarello M, Venditti M, Viale P, Viscoli C, Mazzone A; MEDICAL group; Società Italiana di Terapia Antinfettiva (SITA),; Federazione delle Associazioni dei Dirigenti Ospedalieri Internisti (FADOI).

Eur J Intern Med. 2016 Oct;34:45-53. doi: 10.1016/j.ejim.2016.07.007. Epub 2016 Aug 3.

28.

Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment.

Pafundi PC, Parrella A, Iossa D, Molaro R, Battimelli C, Falco E, Sodano G, Utili R, Durante-Mangoni E.

J Chemother. 2017 Apr;29(2):94-101. doi: 10.1080/1120009X.2016.1171467. Epub 2016 Jun 28.

PMID:
27351356
29.

Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis.

Durante-Mangoni E, Andini R, Parrella A, Mattucci I, Cavezza G, Senese A, Trojaniello C, Caprioli R, Diana MV, Utili R.

Int J Antimicrob Agents. 2016 Jul;48(1):61-68. doi: 10.1016/j.ijantimicag.2016.04.022. Epub 2016 May 25.

PMID:
27259674
30.

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.

Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, Antoniadou A, Carmeli Y, Nutman A, Levi I, Adler A, Durante-Mangoni E, Andini R, Cavezza G, Mouton JW, Wijma RA, Theuretzbacher U, Friberg LE, Kristoffersson AN, Zusman O, Koppel F, Dishon Benattar Y, Altunin S, Paul M; AIDA consortium.

BMJ Open. 2016 Apr 20;6(4):e009956. doi: 10.1136/bmjopen-2015-009956.

31.

Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.

Durante-Mangoni E, Vitrone M, Parrella A, Andini R, Iossa D, Ragone E, Falco E, Maiello C, Utili R, Zampino R.

Transpl Infect Dis. 2016 Jun;18(3):319-25. doi: 10.1111/tid.12525. Epub 2016 May 10.

PMID:
26988401
32.

Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.

Durante-Mangoni E, Pafundi PC, Ravasio V, Barbaro F, Bassetti M, Chinello P, Falcone M, Pasticci MB, Scotton PG, Stellini R, Tripodi MF, Utili R, Rizzi M.

Infection. 2016 Aug;44(4):467-74. doi: 10.1007/s15010-015-0870-y. Epub 2016 Jan 19.

PMID:
26780903
33.

Increased in vitro phenol-soluble modulin production is associated with soft tissue infection source in clinical isolates of methicillin-susceptible Staphylococcus aureus.

Qi R, Joo HS, Sharma-Kuinkel B, Berlon NR, Park L, Fu CL, Messina JA, Thaden JT, Yan Q, Ruffin F, Maskarinec S, Warren B, Chu VH, Fortes CQ, Giannitsioti E, Durante-Mangoni E, Kanafani ZA, Otto M, Fowler VG Jr.

J Infect. 2016 Mar;72(3):302-8. doi: 10.1016/j.jinf.2015.11.002. Epub 2016 Jan 9.

34.

Response to Letter Regarding Article, "Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis".

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE Investigators.

Circulation. 2015 Oct 6;132(14):e184-5. doi: 10.1161/CIRCULATIONAHA.115.016782. No abstract available.

PMID:
26438777
35.

Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.

Durante-Mangoni E, Andini R, Pinto D, Iossa D, Molaro R, Agrusta F, Casillo R, Grimaldi M, Utili R.

J Clin Virol. 2015 Jul;68:37-42. doi: 10.1016/j.jcv.2015.04.017. Epub 2015 Apr 22.

PMID:
26071333
36.

Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.

Durante-Mangoni E, Del Franco M, Andini R, Bernardo M, Giannouli M, Zarrilli R.

Diagn Microbiol Infect Dis. 2015 Jul;82(3):222-6. doi: 10.1016/j.diagmicrobio.2015.03.013. Epub 2015 Mar 25.

PMID:
25858028
37.

Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature.

Andini R, Agrusta F, Mattucci I, Malgeri U, Cavezza G, Utili R, Durante-Mangoni E.

Infection. 2015 Oct;43(5):609-13. doi: 10.1007/s15010-015-0772-z. Epub 2015 Apr 1. Review.

PMID:
25828937
38.

Prevalence and significance of two major inherited thrombophilias in infective endocarditis.

Durante-Mangoni E, Iossa D, Molaro R, Andini R, Mattucci I, Malgeri U, Albisinni R, Utili R.

Intern Emerg Med. 2015 Aug;10(5):587-94. doi: 10.1007/s11739-015-1214-8. Epub 2015 Feb 25.

PMID:
25711313
39.

Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.

Zampino R, Pisaturo MA, Cirillo G, Marrone A, Macera M, Rinaldi L, Stanzione M, Durante-Mangoni E, Gentile I, Sagnelli E, Signoriello G, Miraglia Del Giudice E, Adinolfi LE, Coppola N.

Ann Hepatol. 2015 Jan-Feb;14(1):75-82.

40.

Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; International Collaboration on Endocarditis (ICE) Investigators*.

Circulation. 2015 Jan 13;131(2):131-40. doi: 10.1161/CIRCULATIONAHA.114.012461. Epub 2014 Dec 5.

PMID:
25480814
41.

Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.

Chirouze C, Alla F, Fowler VG Jr, Sexton DJ, Corey GR, Chu VH, Wang A, Erpelding ML, Durante-Mangoni E, Fernández-Hidalgo N, Giannitsioti E, Hannan MM, Lejko-Zupanc T, Miró JM, Muñoz P, Murdoch DR, Tattevin P, Tribouilloy C, Hoen B; ICE Prospective Investigators.

Clin Infect Dis. 2015 Mar 1;60(5):741-9. doi: 10.1093/cid/ciu871. Epub 2014 Nov 10.

42.

Differential antiviral effects of pegylated interferon-α2a and pegylated interferon-α2b in chronic hepatitis C.

Durante-Mangoni E, Parrella A, Iossa D, Andini R, Molaro R, Battimelli C, Sodano G, Utili R.

Clin Drug Investig. 2014 Dec;34(12):871-8. doi: 10.1007/s40261-014-0241-y.

PMID:
25349040
43.

Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression.

Zampino R, Coppola N, Cirillo G, Boemio A, Minichini C, Marrone A, Stanzione M, Starace M, Durante-Mangoni E, Sagnelli E, Restivo L, Salzillo G, Fascione MC, Nevola R, Del Giudice EM, Adinolfi LE.

World J Hepatol. 2014 Sep 27;6(9):677-84. doi: 10.4254/wjh.v6.i9.677.

44.

The role of hemostasis in infective endocarditis.

Durante-Mangoni E, Molaro R, Iossa D.

Curr Infect Dis Rep. 2014 Nov;16(11):435. doi: 10.1007/s11908-014-0435-8.

PMID:
25230604
45.

Does this patient have Ebola virus disease?

Tattevin P, Durante-Mangoni E, Massaquoi M.

Intensive Care Med. 2014 Nov;40(11):1738-41. doi: 10.1007/s00134-014-3473-7. Epub 2014 Sep 3. Review. No abstract available.

46.

Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.

Durante-Mangoni E, Utili R, Zarrilli R.

Future Microbiol. 2014;9(6):773-89. doi: 10.2217/fmb.14.34. Review.

PMID:
25046524
47.

Nosocomial endocarditis: still a challenging diagnosis.

Durante-Mangoni E, Utili R.

Intern Emerg Med. 2014 Oct;9(7):715-6. doi: 10.1007/s11739-014-1105-4. Epub 2014 Jul 13. No abstract available.

PMID:
25016330
48.

Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years.

Durante-Mangoni E, Andini R, Agrusta F, Iossa D, Mattucci I, Bernardo M, Utili R.

Eur J Intern Med. 2014 Sep;25(7):657-61. doi: 10.1016/j.ejim.2014.05.015. Epub 2014 Jun 19.

PMID:
24954705
49.

Combination therapy for carbapenem-resistant Gram-negative bacteria.

Paul M, Carmeli Y, Durante-Mangoni E, Mouton JW, Tacconelli E, Theuretzbacher U, Mussini C, Leibovici L.

J Antimicrob Chemother. 2014 Sep;69(9):2305-9. doi: 10.1093/jac/dku168. Epub 2014 May 28. Review.

PMID:
24872346
50.

Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI).

Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, Pasticci MB, Chinello P, Falcone M, Grossi P, Barbaro F, Pan A, Viale P, Durante-Mangoni E; Investigators of the Italian Study on Endocarditis.

BMC Infect Dis. 2014 Apr 29;14:230. doi: 10.1186/1471-2334-14-230.

Supplemental Content

Loading ...
Support Center